Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial. JAMA. 2019 Apr 9;321(14):1370-1379
view abstract
Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo. Oncotarget. 2016 Jan 5;7(1):995-1013
view abstract
Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study., PLoS One 6: e20796
view abstract
Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men., Cancer Epidemiol Biomarkers Prev 20: 1178-84
view abstract
Serum vitamin D and risk of bladder cancer., Cancer Res 70: 9218-23
view abstract
Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 94-106
view abstract
Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 21-35
view abstract
Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 36-46
view abstract
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 10-20
view abstract
Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 47-57
view abstract
Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 70-80
view abstract
Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 58-69
view abstract
Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study., Cancer Epidemiol Biomarkers Prev 19: 130-4
view abstract
Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma, J Invest Dermatol 130: 1438-43
view abstract
Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer., Br J Cancer 101: 916-23
view abstract
Open letter to IARC Director Christopher P. Wild-Re: IARC Working Group Report 5: Vitamin D and Cancer, Dermatoendocrinol 1: 119-20
view abstract
Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial., Cancer Res 69: 1439-47
view abstract
A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers., Int J Cancer 124: 979-86
view abstract
Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer., J Clin Onco 26: 5596-602
view abstract
Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer., J Clin Oncol 26: 2984-91
view abstract
Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States)., Cancer Causes Control 19: 527-35
view abstract
Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial., Cancer Epidemiol Biomarkers Prev 17: 889-94
view abstract
A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer., J Natl Cancer Inst 99: 1120-9
view abstract
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer., Cancer Epidemiol Biomarkers Prev 16: 783-8
view abstract
Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients, J Clin Oncol 25: 479-85
view abstract
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men, J Natl Cancer Inst 98: 451-9
view abstract
Plasma vitamin D metabolites and risk of colorectal cancer in women., Cancer Epidemiol Biomarkers Prev 13: 1502-8
view abstract
Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk., Cancer Epidemiol Biomarkers Prev 13: 546-52
view abstract
Double bond in the side chain of 1alpha,25-dihydroxy-22-ene-vitamin D(3) is reduced during its metabolism: studies in chronic myeloid leukemia (RWLeu-4) cells and rat kidney., J Steroid Biochem Mol Biol 78: 167-76
view abstract
Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men., Cancer Causes Control 8: 615-25
view abstract
In vivo parathyroid hormone stimulates in vitro bone resorption by bovine monocytes., J Dairy Sci. 78: 2700-8
view abstract
Age and gender effects on 1,25-dihydroxyvitamin D3-regulated gene expression., Exp Gerontol 30: 631-43
view abstract
25-Hydroxyvitamin D3 metabolism in a human leukemia cell line., Calcif Tissue Int 39: 328-33
view abstract
Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups., N Engl J Med 303: 1377-83
view abstract
